RDY - Dr. Reddy's Laboratories Ltd
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
0.13
(+1.56%)
Recent News
- Study shows Crestor cuts heart-attack risk, AstraZeneca says
Nov 10, 6:13 AM EST - (at MarketWatch) - UPDATE - India's Dr Reddy's Q2 net plunges, keeps forecast
Oct 23, 11:03 AM EDT - (at Reuters) - Q2 08/2009 Dr. Reddy's Laboratories Ltd. Earnings Release - Time Not Supplied
Oct 23, 7:07 AM EDT - (CCBN) - Dr. Reddy's Q2 FY09 Revenue at Rs. 16,151 Million, EBITDA at Rs. 2,746 Million, PAT at Rs. 1,212 Million
Oct 23, 6:05 AM EDT - (Business Wire) - Biotech Stocks: Drug stocks head south while Pfizer, Schering-Plough go north
Oct 21, 10:34 AM EDT - (at MarketWatch) - Click Here To See More News...
Open a Brokerage Account and Start Trading Today!
100% Free Stock Trade. Trade stocks for free on Zecco.com. The Free Trading Community. www.zecco.com
100% Free Stock Trade. Trade stocks for free on Zecco.com. The Free Trading Community. www.zecco.com
Copyright © 2008 Stock Market eNews, Inc. All rights reserved.
Financial Market Data powered by QuoteMedia, Inc.
NYSE/AMEX data delayed 20 minutes.
NASDAQ and other data delayed 15 minutes unless indicated.
Views express in blog articles and forums are not necessarily those of Stock Market eNews, Inc.
If you feel some content to be inappropriate, please let us know and we will take care of it immediately.